FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3116896978> ?p ?o ?g. }

• W3116896978 endingPage "72" @default.
• W3116896978 startingPage "67" @default.
• W3116896978 abstract "One of the relevant problems of modern pediatrics is damage to the esophagus during gastroesophageal reflux disease. Purpose of work: study of the efficacy and safety of pantoprazole (Uselapan) and combined synbiotic (Opefera) in the complex therapy of GERD with reflux esophagitis in children with chronic gastroduodenitis (СGD).Materials and methods. 60 children with chronic gastroduodenitis and gastroesophageal reflux disease accompanied by gastroesophageal reflux and esophagitis at the age from 12 to 17 years old who were in hospital were examined. Depending on the infection with H. pylori patients, two surveillance groups were formed: I – 20 children with a diagnosis of GERD with reflux esophagitis and CGD not associated with H. pylori; II – 40 children with GERD with reflux esophagitis and CGD associated with H. pylori. Children from both groups received pantoprazole 40 mg as antisecretory therapy (Ulsepan). To prevent antibiotic-associated diarrhea in children from the 2nd group of observations, we used a pre-and probiotic complex (synbiotic) Opefera.Results and discussion. Based on the results of the evaluation of the dynamics of the disappearance of GERD symptoms against the background of Upsepan PPI (pantoprazole), it was found that in a month of treatment in 90.0% of patients with GERD with reflux esophagitis and CGD non-associated with H. pylori no symptoms of GERD were present, and in the group children of patients with GERD with reflux esophagitis and CHD associated with H. pylori, the absence of GERD symptoms was recorded in 87.5% of patients, statistically significantly less than before the initiation of therapy. It was established that the manifestations of antibiotic-associated diarrhea in children who received synbiotic Opefera from the first day of antibacterial treatment occurred in 5.0% of patients. In the group of children who received the synbiotic after the abolition of the antibiotic, clinical manifestations of antibiotic-associated diarrhea were detected in statistically significant (p <0.05) of a larger number of patients (20.0%).Conclusion. Gastroesophageal reflux disease is an actual pediatric problem, occupying one of the leading places in the structure of gastroenterological diseases in children. The use of pantoprazole (Ulsepan) in the complex therapy of children with gastroesophageal reflux disease with reflux esophagitis and chronic gastroduodenitis in patients over 12 years of age provides a pronounced positive clinical effect. The use of the synbiotic complex Opefera from the first days of H. pylori eradication therapy with antibacterial drugs significantly reduces the manifestations of antibiotic-associated diarrhea in children." @default.
• W3116896978 created "2021-01-05" @default.
• W3116896978 creator A5055529247 @default.
• W3116896978 creator A5059119701 @default.
• W3116896978 date "2017-12-04" @default.
• W3116896978 modified "2023-09-25" @default.
• W3116896978 title "Experience of using pantoprazole (Ulsepan) and combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis" @default.
• W3116896978 doi "https://doi.org/10.37987/1997-9894.2017.9-10(215-6.222477" @default.
• W3116896978 hasPublicationYear "2017" @default.
• W3116896978 type Work @default.
• W3116896978 sameAs 3116896978 @default.
• W3116896978 citedByCount "0" @default.
• W3116896978 crossrefType "journal-article" @default.
• W3116896978 hasAuthorship W3116896978A5055529247 @default.
• W3116896978 hasAuthorship W3116896978A5059119701 @default.
• W3116896978 hasBestOaLocation W31168969781 @default.
• W3116896978 hasConcept C126322002 @default.
• W3116896978 hasConcept C2777014526 @default.
• W3116896978 hasConcept C2777498785 @default.
• W3116896978 hasConcept C2779134260 @default.
• W3116896978 hasConcept C2779920096 @default.
• W3116896978 hasConcept C2781315423 @default.
• W3116896978 hasConcept C2909576783 @default.
• W3116896978 hasConcept C43270747 @default.
• W3116896978 hasConcept C71924100 @default.
• W3116896978 hasConcept C90924648 @default.
• W3116896978 hasConceptScore W3116896978C126322002 @default.
• W3116896978 hasConceptScore W3116896978C2777014526 @default.
• W3116896978 hasConceptScore W3116896978C2777498785 @default.
• W3116896978 hasConceptScore W3116896978C2779134260 @default.
• W3116896978 hasConceptScore W3116896978C2779920096 @default.
• W3116896978 hasConceptScore W3116896978C2781315423 @default.
• W3116896978 hasConceptScore W3116896978C2909576783 @default.
• W3116896978 hasConceptScore W3116896978C43270747 @default.
• W3116896978 hasConceptScore W3116896978C71924100 @default.
• W3116896978 hasConceptScore W3116896978C90924648 @default.
• W3116896978 hasIssue "9-10(215-6" @default.
• W3116896978 hasLocation W31168969781 @default.
• W3116896978 hasOpenAccess W3116896978 @default.
• W3116896978 hasPrimaryLocation W31168969781 @default.
• W3116896978 hasRelatedWork W1517353735 @default.
• W3116896978 hasRelatedWork W2054999064 @default.
• W3116896978 hasRelatedWork W2083204012 @default.
• W3116896978 hasRelatedWork W2384655150 @default.
• W3116896978 hasRelatedWork W2394944086 @default.
• W3116896978 hasRelatedWork W2465160769 @default.
• W3116896978 hasRelatedWork W3116896978 @default.
• W3116896978 hasRelatedWork W4247148866 @default.
• W3116896978 hasRelatedWork W4285154846 @default.
• W3116896978 hasRelatedWork W2739534563 @default.
• W3116896978 hasVolume "0" @default.
• W3116896978 isParatext "false" @default.
• W3116896978 isRetracted "false" @default.
• W3116896978 magId "3116896978" @default.
• W3116896978 workType "article" @default.